CNC | CENTENE UPDATE
Centene has staged a major recovery, with CNC now trading around $65.30 after gaining roughly 57% this year.
The stock trades at 12.34x forward earnings above its five-year median of 11.33x but still below the industry average of 15.20x.
The big question now is whether Centene can sustain its Medicaid margin improvement into 2027.
Investors will be watching margins, Medicaid performance and Marketplace profitability closely.
After such a strong rerating execution matters more than ever.
$CNC.US
$BTC $QQQB
Centene has staged a major recovery, with CNC now trading around $65.30 after gaining roughly 57% this year.
The stock trades at 12.34x forward earnings above its five-year median of 11.33x but still below the industry average of 15.20x.
The big question now is whether Centene can sustain its Medicaid margin improvement into 2027.
Investors will be watching margins, Medicaid performance and Marketplace profitability closely.
After such a strong rerating execution matters more than ever.
$CNC.US
$BTC $QQQB